scholarly journals WHO Polio Eradication Program: Problems and Solutions

2016 ◽  
Vol 13 (3) ◽  
pp. 289-298 ◽  
Author(s):  
S. M. Kharit ◽  
V. S. Pokrovsky ◽  
A. A. Ruleva ◽  
I. V. Fridman
2021 ◽  
Vol 13 (3) ◽  
pp. 215-221
Author(s):  
Teshome Gebre

Abstract There have been various infectious disease eradication programs implemented in various parts of the world with varying degrees of success since the early 1900s. Of all those programs, the one that achieved monumental success was the Smallpox Eradication Program (SEP). Most of the global health leaders and authorities that came up with the new idea of disease eradication in the 1980s tried to design and shape the new programs based on their experience in the SEP. The SEP had a very effective tool, vaccine, that did not require a cold chain system, and a relatively simple way of administration. The total cost of the eradication program was about US$300 million and the entire campaign took about 10 y. However, the Guinea worm and polio eradication programs that followed in the footsteps of SEP attained varying levels of success, consuming a huge amount of resources and taking a much longer time (>30 y each). This paper reviews the factors that played major roles in hindering the attainment of eradication goals and outlines possible recommendations for the way forward. Among other things, this paper strongly emphasizes that endemic countries should take the lead in all matters pertaining to making decisions for disease elimination and/or eradication initiatives and that ‘elimination as a public health problem’ is the preferred option rather than going for complete eradication at the expense of other health programs and thereby contributing to weakening of already fragile health systems, mainly in Africa.


2015 ◽  
Vol 14 (2) ◽  
pp. 73-78 ◽  
Author(s):  
O. E. Ivanova

The review presents data on the current stature of the Global Polio Eradication Initiative of the WHO. The success of its implementation mainly depends on the solutions of the problems associated with continuing use of trivalent oral poliovirus vaccine (OPV): vaccine- associated paralytic poliomyelitis (VAPP) and vaccine-derived polioviruses (VDPV). The information about the polio immunization strategy proposed by WHO in «Polio Eradication and Endgame Strategic Plan 2013 - 2018» is presented.


Sign in / Sign up

Export Citation Format

Share Document